Adipokine gene single-nucleotide polymorphisms in Portuguese obese adolescents: Associations with plasma concentrations of adiponectin, resistin, IL-6, IL-1β, and TNF-α

Childhood Obesity

Volumn 12, Issue 4, 2016, Pages 300-313

  Nascimento, Henrique ^a,b   Vieira, Emília ^c   Coimbra, Susana ^b,d   Catarino, Cristina ^a,b   Costa, Elísio ^a,b   Bronze Da Rocha, Elsa ^a,b   Rocha Pereira, Petronila ^e   Carvalho, Márcia ^f   Ferreira Mansilha, Helena ^b   Rêgo, Carla ^g   Dos Santos, Rosário ^c   Santos Silva, Alice ^a,b   Belo, Luís ^a,b  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c Centro Hospitalar e Universitário do Porto   (Portugal)

^d INSTITUTO DE INVESTIGAÇÃO E FORMAÇÃO AVANÇADA EM CIÊNCIAS E TECNOLOGIAS DA SAÚDE   (Portugal)

^e UNIVERSITY OF BEIRA INTERIOR   (Portugal)

^f CEBIMED   (Portugal)

^g University of Porto   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; RESISTIN; TUMOR NECROSIS FACTOR;

ADOLESCENT; BLOOD; CHILDHOOD OBESITY; COHORT ANALYSIS; FEMALE; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; INSULIN RESISTANCE; MALE; PORTUGAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADIPOKINES; ADOLESCENT; COHORT STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INSULIN RESISTANCE; INTERLEUKIN-1BETA; INTERLEUKIN-6; MALE; PEDIATRIC OBESITY; POLYMORPHISM, SINGLE NUCLEOTIDE; PORTUGAL; RESISTIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84980361810     PISSN: 21532168     EISSN: 21532176     Source Type: Journal    
DOI: 10.1089/chi.2015.0235     Document Type: Article

References (47)

1. Rondinone CM. Adipocyte-derived hormones, cytokines, and mediators. Endocrine 2006;29:81-90.
2. Galic S, Oakhill JS, Steinberg GR. Adipose tissue as an endocrine organ. Mol Cell Endocrinol 2010;316:129-139.
3. Carey AL, Steinberg GR, Macaulay SL, et al. Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase. Diabetes 2006;55:2688-2697.
4. Myers MG, Jr, Leibel RL, Seeley RJ, Schwartz MW. Obesity and leptin resistance: Distinguishing cause from effect. Trends Endocrinol Metab 2010;21:643-651.
5. Procaccini C, Pucino V, Mantzoros CS, Matarese G. Leptin in autoimmune diseases. Metabolism 2015;64:92-104.
6. Abate N, Sallam HS, Rizzo M, et al. Resistin: an inflammatory cytokine. Role in cardiovascular diseases, diabetes and the metabolic syndrome. Curr Pharm Des 2014;20:4961-4969.
7. Ouchi N, Shibata R, Walsh K. Cardioprotection by adiponectin. Trends Cardiovasc Med 2006;16:141-146.
8. Wijnhoven TM, van Raaij JM, Spinelli A, et al. WHO European Childhood Obesity Surveillance Initiative: Body mass index and level of overweight among 6-9-year-old children from school year 2007/2008 to school year 2009/2010. BMC Public Health 2014; 14:806.
9. Bingham DD, Varela-Silva MI, Ferrao MM, et al. Sociodemographic and behavioral risk factors associated with the high prevalence of overweight and obesity in Portuguese children. Am J Hum Biol 2013;25:733-742.
10. Hirte L, Nolte E, Mossialos E, McKee M. The changing regional pattern of ischaemic heart disease mortality in southern Europe: Still healthy but uneven progress. J Epidemiol Community Health 2008;62:e4.
11. Yu Z, Han S, Cao X, et al. Genetic polymorphisms in adipokine genes and the risk of obesity: A systematic review and metaanalysis. Obesity (Silver Spring) 2012;20:396-406.
12. Enquobahrie DA, Rice K, Williams OD, et al. IL1B genetic variation and plasma C-reactive protein level among young adults: The CARDIA study. Atherosclerosis 2009;202:513-520.
13. Bouatia-Naji N, Meyre D, Lobbens S, et al. ACDC/adiponectin polymorphisms are associated with severe childhood and adult obesity. Diabetes 2006;55:545-550.
14. Strandberg L, Mellstrom D, Ljunggren O, et al. IL6 and IL1B polymorphisms are associated with fat mass in older men: The MrOS Study Sweden. Obesity (Silver Spring) 2008;16:710-713.
15. Dalziel B, Gosby AK, Richman RM, et al. Association of the TNFalpha- 308 G/A promoter polymorphism with insulin resistance in obesity. Obes Res 2002;10:401-407.
16. Pausova Z, Deslauriers B, Gaudet D, et al. Role of tumor necrosis factor-alpha gene locus in obesity and obesity-associated hypertension in French Canadians. Hypertension 2000;36: 14-19.
17. Ukkola O, Kunnari A, Kesaniemi YA. Genetic variants at the resistin locus are associated with the plasma resistin concentration and cardiovascular risk factors. Regul Pept 2008;149: 56-59.
18. de Onis M, Onyango AW, Borghi E, et al. Development of a WHO growth reference for school-aged children and adolescents. Bull World Health Organ 2007;85:660-667.
19. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18: 499-502.
20. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419.
21. Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: An alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 1992;39:225-235.
22. Patel S, Flyvbjerg A, Kozakova M, et al. Variation in the ADIPOQ gene promoter is associated with carotid intima media thickness independent of plasma adiponectin levels in healthy subjects. Eur Heart J 2008;29:386-393.
23. Roszkowska-Gancarz M, Bartoszewicz Z, Polosak J, et al. Total and high molecular weight adiponectin and level-modifying polymorphisms of ADIPOQ in centenarians. Endokrynol Pol 2012;63:439-446.
24. Strandberg L, Lorentzon M, Hellqvist A, et al. Interleukin-1 system gene polymorphisms are associated with fat mass in young men. J Clin Endocrinol Metab 2006;91:2749-2754.
25. Huth C, Illig T, Herder C, et al. Joint analysis of individual participants data from 17 studies on the association of the IL6 variant-174G>C with circulating glucose levels, interleukin-6 levels, and body mass index. Ann Med 2009;41:128-138.
26. Goyenechea E, Parra D, Martinez JA. Impact of interleukin 6- 174G>C polymorphism on obesity-related metabolic disorders in people with excess in body weight. Metabolism 2007;56:1643-1648.
27. Rodriguez-Rodriguez L, Gonzalez-Juanatey C, Palomino-Morales R, et al. TNFA-308 (rs1800629) polymorphism is associated with a higher risk of cardiovascular disease in patients with rheumatoid arthritis. Atherosclerosis 2011;216:125-130.
28. El-Shal AS, Pasha HF, Rashad NM. Association of resistin gene polymorphisms with insulin resistance in Egyptian obese patients. Gene 2013;515:233-238.
29. Arraiz N, Escalona C, Prieto C, et al. Polimorfismo 3UTR +62G>A del gen RETN codificante de resistina y asociacion con componentes del sindrome metabolico [3UTR +62G>A polymorphism of the RETN gene coding resistin and its association with metabolic syndrome components]. Med Clin (Barc) 2013; 141:325-331.
30. Qasim AN, Metkus TS, Tadesse M, et al. Resistin gene variation is associated with systemic inflammation but not plasma adipokine levels, metabolic syndrome or coronary atherosclerosis in nondiabetic Caucasians. Clin Endocrinol(Oxf) 2009;70: 698-705.
31. Steinberger J, Daniels SR; American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee (Council on Cardiovascular Disease in the Young), et al. Obesity, insulin resistance, diabetes, and cardiovascular risk in children: An American Heart Association scientific statement from the Atherosclerosis, Hypertension, and Obesity in the Young Committee (Council on Cardiovascular Disease in the Young) and the Diabetes Committee (Council on Nutrition, Physical Activity, and Metabolism). Circulation 2003;107:1448-1453.
32. Morandi A, Maffeis C, Lobbens S, et al. Early detrimental metabolic outcomes of rs17300539-A allele of ADIPOQ gene despite higher adiponectinemia. Obesity (Silver Spring) 2010;18:1469-1473.
33. Woo JG, Dolan LM, Deka R, et al. Interactions between noncontiguous haplotypes in the adiponectin gene ACDC are associated with plasma adiponectin. Diabetes 2006;55:523-529.
34. Kyriakou T, Collins LJ, Spencer-Jones NJ, et al. Adiponectin gene ADIPOQ SNP associations with serum adiponectin in two female populations and effects of SNPs on promoter activity. J Hum Genet 2008;53:718-727.
35. Jang Y, Chae JS, Koh SJ, et al. The influence of the adiponectin gene on adiponectin concentrations and parameters of metabolic syndrome in non-diabetic Korean women. Clin Chim Acta 2008; 391:85-90.
36. Vasseur F, Helbecque N, Dina C, et al. Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians. Hum Mol Genet 2002;11: 2607-2614.
37. Park JY, Lee HJ, Jang HB, et al. Interactions between ADIPOQ gene variants and dietary monounsaturated: Saturated fatty acid ratio on serum lipid levels in Korean children. Nutr Metab Cardiovasc Dis 2014;24:83-90.
38. Lau CH, Muniandy S. Adiponectin and resistin gene polymorphisms in association with their respective adipokine levels. Ann Hum Genet 2011;75:370-382.
39. Mousavinasab F, Tahtinen T, Jokelainen J, et al. Common polymorphisms (single-nucleotide polymorphisms SNP +45 and SNP +276) of the adiponectin gene regulate serum adiponectin concentrations and blood pressure in young Finnish men. Mol Genet Metab 2006;87:147-151.
40. Maedler K, Sergeev P, Ris F, et al. Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets. J Clin Invest 2002;110:851-860.
41. Chen H, Wilkins LM, Aziz N, et al. Single nucleotide polymorphisms in the human interleukin-1B gene affect transcription according to haplotype context. Hum Mol Genet 2006;15:519-529.
42. Qian N, Chen X, Han S, et al. Circulating IL-1β levels, polymorphisms of IL-1B, and risk of cervical cancer in Chinese women. J Cancer Res Clin Oncol 2010;136:709-716.
43. Kroeger KM, Carville KS, Abraham LJ. The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription. Mol Immunol 1997;34:391-399.
44. Simons PJ, van den Pangaart PS, Aerts JM, Boon L. Proinflammatory delipidizing cytokines reduce adiponectin secretion from human adipocytes without affecting adiponectin oligomerization. J Endocrinol 2007;192:289-299.
45. Bokarewa M, Nagaev I, Dahlberg L, et al. Resistin, an adipokine with potent proinflammatory properties. J Immunol 2005;174: 5789-5795.
46. Boumaiza I, Omezzine A, Rejeb J, et al. Association between four resistin polymorphisms, obesity, and metabolic syndrome parameters in Tunisian volunteers. Genet Test Mol Biomarkers 2012;16: 1356-1362.
47. Nascimento H, Silva L, Lourenco P, et al. Lipid profile in Portuguese obese children and adolescents: Interaction of apolipoprotein E polymorphism with adiponectin levels. Arch Pediatr Adolesc Med 2009;163:1030-1036.